Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis

被引:46
|
作者
Frey, Melissa K. [1 ,6 ]
Ahsan, Muhammad Danyal [1 ]
Bergeron, Hannah [1 ]
Lin, Jenny [1 ]
Li, Xuan [1 ]
Fowlkes, Rana K. [1 ]
Narayan, Priyanka [1 ]
Nitecki, Roni [2 ]
Rauh-Hain, Jose Alejandro [2 ]
Moss, Haley A. [3 ]
Baltich Nelson, Becky [1 ]
Thomas, Charlene [1 ]
Christos, Paul J. [1 ]
Hamilton, Jada G. [4 ]
Chapman-Davis, Eloise [1 ]
Cantillo, Evelyn [1 ]
Holcomb, Kevin [1 ]
Kurian, Allison W. [5 ]
Lipkin, Steven [1 ]
Offit, Kenneth [4 ]
Sharaf, Ravi N. [1 ]
机构
[1] Weill Cornell Med, New York, NY USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Memorial Sloan Kettering Canc Ctr, New York, NY USA
[5] Stanford Univ, Sch Med, Palo Alto, CA USA
[6] Weill Cornell Med, Div Gynecol Oncol, 525 East 68th St,Suite J 130, New York, NY 10065 USA
关键词
NONPOLYPOSIS COLORECTAL-CANCER; BRCA MUTATION CARRIERS; BREAST-OVARIAN CANCER; LYNCH-SYNDROME; FAMILY COMMUNICATION; GENETIC INFORMATION; UPTAKE RATES; RISK; DISCLOSURE; WOMEN;
D O I
10.1200/JCO.22.00303
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSEEvidence-based guidelines recommend cascade genetic counseling and testing for hereditary cancer syndromes, providing relatives the opportunity for early detection and prevention of cancer. The current standard is for patients to contact and encourage relatives (patient-mediated contact) to undergo counseling and testing. Direct relative contact by the medical team or testing laboratory has shown promise but is complicated by privacy laws and lack of infrastructure. We sought to compare outcomes associated with patient-mediated and direct relative contact for hereditary cancer cascade genetic counseling and testing in the first meta-analysis on this topic.MATERIALS AND METHODSWe conducted a systematic review and meta-analysis in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (PROSPERO No.: CRD42020134276). We searched key electronic databases to identify studies evaluating hereditary cancer cascade testing. Eligible trials were subjected to meta-analysis.RESULTSEighty-seven studies met inclusion criteria. Among relatives included in the meta-analysis, 48% (95% CI, 38 to 58) underwent cascade genetic counseling and 41% (95% CI, 34 to 48) cascade genetic testing. Compared with the patient-mediated approach, direct relative contact resulted in significantly higher uptake of genetic counseling for all relatives (63% [95% CI, 49 to 75] v 35% [95% CI, 24 to 48]) and genetic testing for first-degree relatives (62% [95% CI, 49 to 73] v 40% [95% CI, 32 to 48]). Methods of direct contact included telephone calls, letters, and e-mails; respective rates of genetic testing completion were 61% (95% CI, 51 to 70), 48% (95% CI, 37 to 59), and 48% (95% CI, 45 to 50).CONCLUSIONMost relatives at risk for hereditary cancer do not undergo cascade genetic counseling and testing, forgoing potentially life-saving medical interventions. Compared with patient-mediated contact, direct relative contact increased rates of cascade genetic counseling and testing, arguing for a shift in the care delivery paradigm, to be confirmed by randomized controlled trials.
引用
下载
收藏
页码:4129 / +
页数:31
相关论文
共 50 条
  • [1] Cascade testing for hereditary cancer syndromes: Should we move towards direct relative contact? A systematic review and meta-analysis
    Ahsan, Muhammad Danyal
    Bergeron, Hannah
    Lin, Jenny
    Fowlkes, Rana
    Narayan, Priyanka
    Nitecki, Roni
    Rauh-Hain, Jose
    Moss, Haley
    Li, Xuan
    Thomas, Charlene
    Christos, Paul
    Feit, Julia
    Chapman-Davis, Eloise
    Cantillo, Evelyn
    Holcomb, Kevin
    Lipkin, Steven
    Sharaf, Ravi
    Frey, Melissa
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S196 - S196
  • [2] Cascade genetic testing for hereditary cancer syndromes: A systematic review and meta-analysis
    Li, X.
    Kahn, R. M.
    Lackner, A. I.
    Nelson, B. Baltich
    Krinsky, H.
    Mei, E.
    Badiner, N.
    Holcomb, K. M.
    Chapman-Davis, E.
    Nitecki, R.
    Rauh-Hain, J. A.
    Sharaf, R.
    Frey, M. K.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 251 - 252
  • [3] Relative disclosure of information on hereditary cancer syndromes: A systematic review and meta-analysis.
    Ahsan, Muhammad Danyal
    Bergeron, Hannah
    Lin, Jenny
    Narayan, Priyanka
    Nelson, Becky Baltich
    Li, Xuan
    Thomas, Charlene
    Christos, Paul J.
    Chapman-Davis, Eloise
    Cantillo, Evelyn
    Holcomb, Kevin
    Sharaf, Ravi
    Frey, Melissa Kristen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] Cascade Testing for hereditary Cancer Diseases: A Meta-Analysis
    Lackner, A.
    Li, X.
    Kahn, R.
    Nelson, Baltich B.
    Krinsky, H.
    Mei, E.
    Badiner, N.
    Caputo, T. A.
    Holcomb, K.
    Chapman-Davis, E.
    Nitecki, R.
    Rauh-Hain, J. A.
    Sharaf, R.
    Frey, M. K.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E197 - E198
  • [5] Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
    Jianbang Chiang
    Ziyang Chua
    Jia Ying Chan
    Ashita Ashish Sule
    Wan Hsein Loke
    Elaine Lum
    Marcus Eng Hock Ong
    Nicholas Graves
    Joanne Ngeow
    npj Genomic Medicine, 9
  • [6] Strategies to improve implementation of cascade testing in hereditary cancer syndromes: a systematic review
    Chiang, Jianbang
    Chua, Ziyang
    Chan, Jia Ying
    Sule, Ashita Ashish
    Loke, Wan Hsein
    Lum, Elaine
    Ong, Marcus Eng Hock
    Graves, Nicholas
    Ngeow, Joanne
    NPJ GENOMIC MEDICINE, 2024, 9 (01)
  • [7] Cascade testing for hereditary Tumors: A Meta-Analysis
    Lackner, A.
    Li, X.
    Kahn, R.
    Baltich, Nelson B.
    Krinsky, H.
    Mei, E.
    Badiner, N.
    Caputo, T. A.
    Holcomb, K.
    Chapman-Davis, E.
    Nitecki, R.
    Rauh-Hain, J. A.
    Sharaf, R.
    Frey, M. K.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (06) : E18 - E18
  • [8] DIAGNOSTIC YIELD OF ENDOSCOPIC SCREENING FOR GASTRIC CANCER IN INDIVIDUALS WITH HEREDITARY CANCER SYNDROMES: A META-ANALYSIS AND SYSTEMATIC REVIEW
    Bar-Mashiah, Ariel
    Li, Zixuan
    Sinha, Soham
    Sharaf, Ravi
    GASTROENTEROLOGY, 2022, 162 (07) : S296 - S296
  • [9] Cascade genetic testing for hereditary cancer syndromes: a review of barriers and breakthroughs
    Levine, Rachel
    Kahn, Ryan M.
    Perez, Luiza
    Brewer, Jesse
    Ratner, Samantha
    Li, Xuan
    Yeoshoua, Effi
    Frey, Melissa K.
    FAMILIAL CANCER, 2024, 23 (02) : 111 - 120
  • [10] Socio-ecological model of barriers to cascade testing for hereditary cancer syndromes: Systematic review of the literature
    Li, Xuan
    Ahsan, Muhammad Danyal
    Feit, Julia
    Ratner, Samantha
    Holcomb, Kevin
    Chapman-Davis, Eloise
    Cantillo, Evelyn
    Frey, Melissa
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S38 - S39